NASDAQ : CDNA
CareDx, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 71.52 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.70B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.49B |
| Enterprise Value | 4.27B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 52.54M |
| Shares Outstanding | 52.54M |
| Shares Change (YoY) | -7.68% |
| Shares Change (QoQ) | +6.83% |
| Owned by Insiders (%) | 4.34% |
| Owned by Institutions (%) | 99.15% |
| Float | 50.26M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 35.42 |
| Forward PE | 57.86 |
| PS Ratio | 9.23 |
| Forward PS | 8.60 |
| PB Ratio | 9.81 |
| P/TBV Ratio | 22.30 |
| P/FCF Ratio | 76.86 |
| P/OCF Ratio | 66.54 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 33.98 |
| EV / Sales | 8.79 |
| EV / EBITDA | 170.60 |
| EV / EBIT | 558.49 |
| EV / FCF | 73.15 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.31 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | 0.49 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 33.04% |
| Return on Assets (ROA) | 0.91% |
| Return on Invested Capital (ROIC) | 4.94% |
| Return on Capital Employed (ROCE) | 1.56% |
| Weighted Average Cost of Capital (WACC) | 17.25% |
| Revenue Per Employee | $650,191 |
| Profits Per Employee | $168,142 |
| Employee Count | 765 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 7.71 |
Taxes
| Measure | Value |
|---|
| Income Tax | -4.41M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.38 |
| 52-Week Price Change | +470.27% |
| 50-Day Moving Average | 60.67 |
| 200-Day Moving Average | 33.97 |
| Relative Strength Index (RSI) | 77.42 |
| Average Volume (20 Days) | 1,389,032 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6.72M |
| Short Previous Month | 6.59M |
| Short % of Shares Out | 12.78% |
| Short % of Float | 13.36% |
| Short Ratio (days to cover) | 4.56 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 497.40M |
| Gross Profit | 353.00M |
| Operating Income | 7.83M |
| Pretax Income | 124.22M |
| Net Income | 128.63M |
| EBITDA | 25.62M |
| EBIT | 7.83M |
| Earnings Per Share (EPS) | $2.41 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 250.48M |
| Total Debt | 29.00M |
| Net Cash | 221.48M |
| Net Cash Per Share | $4.22 |
| Equity (Book Value) | 467.46M |
| Book Value Per Share | 8.91 |
| Working Capital | 182.32M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 69.02M |
| Capital Expenditures | -9.26M |
| Depreciation & Amortization | 17.80M |
| Net Borrowing | n/a |
| Free Cash Flow | 59.76M |
| FCF Per Share | $1.14 |
Margins
| Measure | Value |
|---|
| Gross Margin | 70.97% |
| Operating Margin | 1.57% |
| Pretax Margin | 24.97% |
| Profit Margin | 25.86% |
| EBITDA Margin | 5.15% |
| EBIT Margin | 1.57% |
| FCF Margin | 12.01% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.68% |
| Shareholder Yield | 7.68% |
| Earnings Yield | 2.82% |
| FCF Yield | 1.30% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $93.50 |
| Price Target Difference | 9.47% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 16.95% |
| EPS Growth Forecast (3Y) | 56.66% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.69 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |